- Details
- Description
Strength:
Sorafenib Tosylate INN 200 mg
Composition:
Sorafenib Tosylate 200 mg
Treatment:
Hepatocellular carcinoma (HCC), Renal cell carcinoma (RCC)
Form:
Tablet
Brand:
Hepanib
Quantity Unit:
Tablets
Manufacturer:
Everest Pharmaceuticals Ltd.
Hepanib is an oral targeted anticancer medicine containing Sorafenib Tosylate 200 mg. Sorafenib is a multikinase inhibitor that helps block signaling pathways involved in tumor-cell growth and blood-vessel formation. It is used in the treatment of certain cancers, including hepatocellular carcinoma and renal cell carcinoma, under specialist medical supervision.
